HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of pentoxifylline with aspirin in the treatment of frostbite in rats.

Abstract
The efficacy of pentoxifylline--a haemorrheologic agent along with aspirin--an analgesic agent was evaluated in the amelioration of the tissue damage due to experimentally induced frostbite in 5 groups (20 each) of rats with body weights ranging between 175 and 200 g. Frostbite was produced experimentally in the hind limbs by exposing the animals to -15 +/- 1 degrees C for 1 h using the harness technique, with simultaneous recording of rectal and environmental temperatures. The degree of tissue damage was assessed on the basis of tissue necrosis after 15 days. Administration of pentoxifylline (40 mg/kg bw) 30 min before and 30 min after the cold exposure followed by two doses of the same daily for the next 5 days along with aspirin (5 mg/kg bw) twice daily for the same duration only after cold exposure, resulted in significant improvement in the degree of tissue preservation. The findings of this preliminary study have brought to light the potential usefulness of these drugs in the treatment of frostbite. The combined pharmacological properties of these two drugs might have altered the haemorrheologic status of blood and produced the curative beneficial effect in improving tissue survival following experimentally induced frostbite in rats.
AuthorsS S Purkayastha, A Roy, S K Chauhan, S S Verma, W Selvamurthy
JournalThe Indian journal of medical research (Indian J Med Res) Vol. 107 Pg. 239-45 (May 1998) ISSN: 0971-5916 [Print] India
PMID9670622 (Publication Type: Journal Article)
Chemical References
  • Platelet Aggregation Inhibitors
  • Vasodilator Agents
  • Aspirin
  • Pentoxifylline
Topics
  • Animals
  • Aspirin (therapeutic use)
  • Cold Temperature
  • Drug Therapy, Combination
  • Female
  • Frostbite (drug therapy)
  • Male
  • Necrosis
  • Pentoxifylline (therapeutic use)
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: